Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome

about

Live birth rate after human chorionic gonadotropin priming in vitro maturation in women with polycystic ovary syndrome

Item

http://www.wikidata.org/entity/Q58701046

description

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Live birth rate after human ch ...... with polycystic ovary syndrome

@en

Live birth rate after human ch ...... with polycystic ovary syndrome

@nl

type

Item

label

Live birth rate after human ch ...... with polycystic ovary syndrome

@en

Live birth rate after human ch ...... with polycystic ovary syndrome

@nl

prefLabel

Live birth rate after human ch ...... with polycystic ovary syndrome

@en

Live birth rate after human ch ...... with polycystic ovary syndrome

@nl

P1476

Live birth rate after human ch ...... with polycystic ovary syndrome

@en

P2093

A H Le

http://www.w3.org/2001/XMLSchema#string

L N Vuong

http://www.w3.org/2001/XMLSchema#string

T D Pham

http://www.w3.org/2001/XMLSchema#string

T M Ho

http://www.w3.org/2001/XMLSchema#string

V N A Ho

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro maturation in subfertile women with polycystic ovarian syndrome undergoing assisted reproduction

In vitro maturation of human oocytes: Its role in infertility treatment and new possibilities

In Vitro Maturation in Women with vs. without Polycystic Ovarian Syndrome: A Systematic Review and Meta-Analysis

Pregnancy after in vitro fertilization of human follicular oocytes collected from nonstimulated cycles, their culture in vitro and their transfer in a donor oocyte program

Laboratory and embryological aspects of hCG-primed in vitro maturation cycles for patients with polycystic ovaries

Human chorionic gonadotrophin priming for fertility treatment with in vitro maturation.

Obstetric outcomes and congenital abnormalities in infants conceived with oocytes matured in vitro.

IVM results are comparable and may have advantages over standard IVF.

Human chorionic gonadotropin: does it affect human endometrial morphology in vivo?

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

P2888

s13048-018-0445-5

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13048-018-0445-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2018-08-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1106369969

http://www.w3.org/2001/XMLSchema#string

P698

30149808

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

6112143

http://www.w3.org/2001/XMLSchema#string